The EU came up short in running any pan-European clinical trials to advance the development of COVID-19 vaccines and therapies. It is now trying to fix the problem and be better prepared for future health emergencies
The annual EU budget negotiations are done, but the Brussels research circles are ‘fatigued’ with the fight over whether to return unspent money into the €95.5 billion funding pot
A podcast on research evaluation reform. Episode 6 hosted by: Dr Andrew Plume, Vice President, Research Evaluation, Elsevier & President, International Center for the Study of Research. Special guest: Dr Bianca Langhout, Project Manager, Recognition and Rewards & Evaluating Societal Impact, Erasmus University Rotterdam. Listen to more episodes of the series here
Locked out of the EU research programme, Swiss universities are nervous of losing money set aside for association. Parliamentarians now want to protect this cash in a ‘Horizon Fund’
EU’s innovation fund will give out €1.6B in grants and equity to start-ups and innovators in 2023 – and is promising smooth sailing after a bumpy start
Experts believe that new uses of real-world data could help address Europe’s health challenges, if trust is built into the system. A high-level event in Berlin, convened by Science|Business and EIT Health, explored the potential ways forward
At the third transatlantic Trade and Technology Council, Brussels and Washington agreed to draw up shared AI terminology and technical standards. But the two are still a way apart on how to regulate the technology
Seaweed is increasingly important as a raw material. But while plans to scale up farming have been welcomed for highlighting this potential, they are also seen as overlooking innovation in the industry
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.